Both were changed accordingly after downregulating or upregulating CDK2-AP1, which indicates a possible role of the CDK2-AP1/CDK2/CyclinD1 cell cycle pathway in the initiation and progression of breast cancer. The gene discussed is CCND1; the disease is breast cancer.